Clinical research shows that dual peptide medications produce stronger results than single-agent options
Transportin 1 accumulates specifically with FET proteins but no other transportin cargos in FTLD-FUS and is absent in FUS inclusions in ALS with FUS mutations
The CORALreef Lipids trial showed that oncedaily oral enlicitide produced large, durable reductions in LDL cholesterol, nonHDL cholesterol, apolipoprotein B, and lipoprotein(a) over one year in adults with or at risk for atherosclerotic cardiovascular disease, with substantially more participants achieving guideline LDL targets compared with placebo and with a safety profile similar between groups
Are any RMF tasks off limits to automation
The crucial factor in WCM studies is the prediction of invasions and developing WCM management strategies at multi-area scales, which could play an essential role in identifying high-risk areas
Schedule your consultation with Dr